Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

India’s PM Ponders Ways To Encourage Innovative Drug Work

This article was originally published in PharmAsia News

Executive Summary

India's prime minister is considering a proposal for the government to support the kind of medical research the pharmaceutical industry finds too expensive and risky to undertake. The proposal is part of a package of regulatory reforms being studied to encourage drug discovery, support clinical trials and provide approvals of products at different stages of development. The package is part of a $2 billion drug research funding plan that emerged from a series of meetings with drug makers to identify roadblocks that stand in the way of innovative drugs. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071263

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel